1. Home
  2. Stocks
  3. Camlinfine Share Price

Camlin Fine Sciences Share Price

Chemicals Small Cap

₹110.93 +2.75 (2.54%)

05 Nov, 2024 17:15

SIP TrendupStart SIP in CAMLINFINE

Start SIP
Performance Financial Technical Events FnO Shareholding Pattern More FAQ’s

Performance

  • Low
  • ₹107
  • High
  • ₹112
  • 52 Week Low
  • ₹80
  • 52 Week High
  • ₹143
  • Open Price₹108
  • Previous Close₹108
  • Volume841,482

Investment Returns

  • Over 1 Month + 8.72%
  • Over 3 Month -4.66%
  • Over 6 Month + 6.87%
  • Over 1 Year -19.67%
SIP Lightning

Smart Investing Starts Here Start SIP with Camlin Fine Sciences for Steady Growth!

Camlin Fine Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -13.1
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 1,858
  • P/B Ratio
  • 2.3
  • Average True Range
  • 4.63
  • EPS
  • -2.9
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.37
  • RSI
  • 57.12
  • MFI
  • 61.14

Camlin Fine Sciences Financial

IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations181.91220.33185.61206.21161.11
Total Income From Operations181.91220.33185.61206.21161.11
P/L Before Interest, Excpt. Items & Tax-3.98-32.88-4.3914.5819.31
P/L Before Exceptional Items & Tax-17.60-46.75-17.69-0.527.26
P/L After Tax from Ordinary Activities-13.68-44.07-11.64-1.465.78
Net Profit/Loss For the Period-13.68-44.07-11.64-1.465.78
IndicatorMar 24Mar 23
Revenue From Operations [Gross]756.13780.51
Revenue From Operations [Net]756.13780.51
Total Operating Revenues773.26789.44
Total Revenue792.14818.27
Total Expenses849.85751.64
Profit/Loss Before Tax-59.6366.63
Profit/Loss For The Period-51.3947.55
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity82.1018.52
Net Cash Used In Investing Activity-51.72-114.73
Net Cash Used in Finance Activity-34.0578.39
Net Inc/Dec In Cash And Equivalent-3.67-17.82
Cash And Equivalent End Of Year0.684.35
IndicatorMar 24Mar 23
Total Share Capital16.7515.71
Total Non-Current Liabilities248.82322.10
Total Current Liabilities607.46629.57
Total Capital And Liabilities1,571.991,593.81
Total Non-Current Assets711.49718.09
Total Current Assets860.50875.72
Total Assets1,571.991,593.81
Indicator20242023
EBIT Margin (%)-0.4315.65
Return On Capital Employed (%)-0.3512.81
Return On Equity (%)-7.217.44
Long Term Debt To Equity (%)31.2045.75
Book Value/Share (INR)42.5440.67
IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations395.85401.69385.89405.88419.60
Total Income From Operations395.85401.69385.89405.88419.60
P/L Before Interest, Excpt. Items & Tax-0.11-27.534.417.6926.30
P/L Before Exceptional Items & Tax-23.48-43.70-9.73-12.0916.08
P/L After Tax from Ordinary Activities-34.65-81.79-14.28-20.8312.02
Net Profit/Loss For the Period-34.65-81.79-14.28-20.8312.02
IndicatorMar 24Mar 23
Revenue From Operations [Gross]1,595.021,671.30
Revenue From Operations [Net]1,595.021,671.30
Total Operating Revenues1,613.061,681.56
Total Revenue1,628.621,687.36
Total Expenses1,678.061,597.31
Profit/Loss Before Tax-99.2480.38
Profit/Loss For The Period-104.8839.81
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity138.9850.90
Net Cash Used In Investing Activity-66.50-124.63
Net Cash Used in Finance Activity-85.9759.66
Net Inc/Dec In Cash And Equivalent-13.49-14.07
Cash And Equivalent End Of Year80.2593.74
IndicatorMar 24Mar 23
Total Share Capital16.7515.71
Total Non-Current Liabilities362.50443.03
Total Current Liabilities732.27792.99
Total Capital And Liabilities1,951.722,060.10
Total Non-Current Assets951.06972.28
Total Current Assets1,000.671,087.82
Total Assets1,951.722,060.10
Indicator20242023
EBIT Margin (%)0.678.83
Return On Capital Employed (%)0.8911.72
Return On Equity (%)-11.356.92
Long Term Debt To Equity (%)40.7454.25
Book Value/Share (INR)48.2948.18

Camlin Fine Sciences Technicals

EMA & SMA

Current Price
₹110.93
+ 2.75 (2.54%)
pointer
  • stock-down_img
  • Bullish Moving Average 15
  • stock-up_img
  • Bearish Moving Average 1
  • 20 Day
  • ₹103.88
  • 50 Day
  • ₹104.46
  • 100 Day
  • ₹105.97
  • 200 Day
  • ₹111.77

Resistance and Support

108.11 Pivot Speed
  • R3 114.20
  • R2 112.15
  • R1 110.16
  • S1 106.12
  • S2 104.07
  • S3 102.08

Is Camlin Fine Sciences Worth Buying?

BUY SELL HOLD

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Camlin Fine Sciences manufactures specialty chemicals, including antioxidants and aroma chemicals. The company operates facilities in India and internationally, serving industries such as food, feed, pharmaceuticals, and petrochemicals with high-quality, sustainable chemical solutions. Camlin Fine Sciences has an operating revenue of Rs. 1,589.31 Cr. on a trailing 12-month basis. An annual revenue de-growth of -3% needs improvement, Pre-tax margin of -6% needs improvement, ROE of -11% is poor and needs improvement. The company has a reasonable debt to equity of 41%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 13% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 6 which is a POOR score indicating inconsistency in earnings, a RS Rating of 23 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 70 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Camlin Fine Sciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-11 Quarterly Results
2024-08-12 Quarterly Results
2024-05-20 Audited Results
2024-02-09 Quarterly Results
2023-11-06 Quarterly Results

Camlin Fine Sciences F&O

Camlin Fine Sciences Shareholding Pattern

48.02%
4.23%
0.81%
0%
34.52%
12.42%
  • NSE Symbol
  • CAMLINFINE
  • BSE Symbol
  • 532834
  • Chairman & Managing Director
  • Mr. Ashish Dandekar
  • ISIN
  • INE052I01032

Camlin Fine Sciences FAQs

Camlin Fine Sciences share price is ₹110 As on 05 November, 2024 | 17:01

The Market Cap of Camlin Fine Sciences is ₹1858 Cr As on 05 November, 2024 | 17:01

The P/E ratio of Camlin Fine Sciences is -13.1 As on 05 November, 2024 | 17:01

The PB ratio of Camlin Fine Sciences is 2.3 As on 05 November, 2024 | 17:01

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

The Vigilance Awareness Week for the year 2024 (VAW 2024) would be observed from October 28, 2024 to November 03, 2024
“सत्यनिष्ठा की संस्कृनि सेराष्र की समद्ृधि” “Culture of Integrity for Nation's Prosperity”
e-pledge link (https://pledge.cvc.nic.in/)

5paisa Capital Ltd. CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

*Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

Contact Us

Attention Investors

  • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
  • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Email: support@5paisa.com

Support Desk Helpline: 8976689766

©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.